Abstract
The usefulness of 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy in predicting the effectiveness of beta-blocker therapy in dilated cardiomyopathy (DCM) was investigated from the standpoint of long-term prognosis. The subjects were 53 DCM patients in whom beta-blockers had been successfully introduced and used for 6 months or longer. When symptoms were stable before the introduction of beta-blockers and for up to 1 year thereafter, MIBG myocardial single-photon emission computed tomography was performed and the images analysed to obtain the extent score (EXT), severity score (SEV) and washout rate (WR). At the same time, echocardiography was performed to measure left ventricular ejection fraction (LVEF). Thereafter, patients were placed under observation for an average of 1,314+/-986 days, with the occurrence of cardiac events as the endpoint. The degree of improvement in WR after introduction of beta-blockers was a significant predictor of cardiac events. In fact, none of the patients whose improvement in WR was valued at 10 or higher had cardiac events. Accordingly, using improvement in WR of 10 as the cut-off value, the patients were divided into two groups, "improved" and "unimproved". There were significant di...Continue Reading
Citations
Feb 3, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Shohei Yamashina, Jun-ichi Yamazaki
Apr 24, 2007·European Journal of Nuclear Medicine and Molecular Imaging·Shohei Yamashina, Jun-ichi Yamazaki
Aug 13, 2009·European Journal of Nuclear Medicine and Molecular Imaging·Raffaele GiubbiniMaurizio Dondi
Apr 5, 2011·Annals of Nuclear Medicine·Mitsuru MomoseShuji Sakai
Dec 8, 2011·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Ji ChenErnest V Garcia
Nov 29, 2012·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Mark I Travin
Jun 3, 2008·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Maureen M HennemanJeroen J Bax
Mar 6, 2009·Circulation Journal : Official Journal of the Japanese Circulation Society·Shuji NanjoJunichi Yamazaki
Jan 1, 2013·Clinical and Translational Imaging : Reviews in Nuclear Medicine and Molecular Imaging·Nagara TamakiKeiichiro Yoshinaga
Jun 22, 2012·PloS One·Matthias BauwensAlfons Verbruggen
Jan 16, 2007·Current Opinion in Biotechnology·Valle Camacho, Ignasi Carrió
Mar 20, 2008·European Heart Journal·Hein J VerberneBerthe L F van Eck-Smit
Feb 6, 2017·Heart Failure Reviews·George AngelidisPanagiotis Georgoulias
Dec 17, 2010·World Journal of Cardiology·Shinro MatsuoSeigo Kinuya
Nov 22, 2007·Annals of Nuclear Medicine·Hitoshi NagamatsuHiroshi Kasanuki
Jul 25, 2008·Nature Clinical Practice. Cardiovascular Medicine·Hyung J ChunJoseph C Wu
May 24, 2011·European Journal of Heart Failure·Shinji HisatakeJunichi Yamazaki
Jan 20, 2005·Nuclear Medicine Communications·Shinichiro FujimotoJunichi Yamazaki
May 10, 2020·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Christopher L Schumann, Jamieson M Bourque
Jan 28, 2021·Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology·Jason G E ZeltLisa M Mielniczuk
Jun 17, 2020·Seminars in Nuclear Medicine·Gedaliah FarberBenjamin H Rotstein
Aug 10, 2013·Journal of Nuclear Medicine Technology·Lioe-Fee de Geus-OeiHanneke W M van Laarhoven